Content Dam Diq Online Articles 2016 10 Dreamstime Rocket Thumb

Anti-inflammatory versus antibacterial

Oct. 10, 2016
Richard H. Nagelberg, DDS, says using anti-inflammatory meds as part of the treatment plan for patients with periodontitis appears to have merit, but the primary objective should be knocking down the cause—namely the bacteria. But how do we know how effective our bacterial reduction efforts are? Read more in Dr. Nagelberg’s DentistryIQ blog, “Making the Oral-Systemic Connection,” as he discusses the role of salivary testing in treating periodontal disease.

A lot has been written lately about managing the inflammatory aspects of periodontal disease. After all, it is the body’s inflammatory response that is causing hard and soft periodontal tissue destruction.

When a patient presents to the office with periodontitis, an anti-inflammatory protocol may be indicated. Another way of thinking about this is revealed, however, if we go further back in the disease process. What causes mobilization of the inflammatory response in the first place? Bacterial invasion of the gingival epithelial cells is the trigger that ignites the body’s immune-inflammatory response, which is accompanied by the release of enzymes that destroy the gums and bone.

Using anti-inflammatory meds as part of the treatment plan appears to have merit, but the primary objective should be knocking down the cause—namely the bacteria. How do we know how effective our bacterial reduction efforts were? We don’t, unless we provide salivary testing both pre- and postop.

This is not rocket science, but sometimes the simplest solutions are the most difficult to see.

READ MORE OF DR. NAGELBERG’S BLOGS . . .

Richard H. Nagelberg, DDS, has practiced general dentistry in suburban Philadelphia for more than 30 years. He is a speaker, advisory board member, consultant, and key opinion leader for several dental companies and organizations. He lectures on a variety of topics centered on understanding the impact dental professionals have beyond the oral cavity. Contact Dr. Nagelberg at [email protected].

For the most current dental headlines, click here.

About the Author

Richard H. Nagelberg, DDS

Richard H. Nagelberg, DDS, has practiced general dentistry in suburban Philadelphia for more than 30 years. He has served on many advisory boards and as a consultant and key opinion leader for a variety of companies and organizations. Dr. Nagelberg is the Director of Medical Affairs at OraPharma, a division of Bausch Health US, LLC. His practice and other professional activities are centered on the impact dental professionals have beyond the oral cavity. Contact Dr. Nagelberg at [email protected].

Updated May 2022